# Best Regulatory Information Management (RIM) Systems - Page 4 ## How Many Regulatory Information Management (RIM) Systems Products Does G2 Track? **Total Products under this Category:** 59 ### Category Stats (Aug 2026) - **Average Rating:** 4.63/5 The average rating of products in this category, based on all submitted ratings - **Top Trending Product:** Qualio (+0.07%) - Among all products in this category, Qualio recorded the largest rating increase compared to last month _Last updated: August 04, 2026_ ## How Does G2 Rank Regulatory Information Management (RIM) Systems Products? **Why You Can Trust G2's Software Rankings:** - 30 Analysts and Data Experts - 1,500+ Authentic Reviews - 59+ Products - Unbiased Rankings G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category. ## G2 Grid® for Regulatory Information Management (RIM) Systems ![G2 Grid® for Regulatory Information Management (RIM) Systems plotting products by satisfaction and market presence](https://www.g2.com/categories/regulatory-information-management-rim-systems/grids.png?focus%5B%5D=121109&focus%5B%5D=1208617&focus%5B%5D=1315744&focus%5B%5D=75336&focus%5B%5D=134478) Highlighted products: Rimsys, RegDesk, Kivo, Veeva Vault RIM, and Clinical Research Suite. Underlying data: [Grid® JSON](https://www.g2.com/categories/regulatory-information-management-rim-systems/grids.json?focus%5B%5D=rimsys&focus%5B%5D=regdesk&focus%5B%5D=kivo&focus%5B%5D=veeva-vault-rim&focus%5B%5D=clinical-research-suite) **Sponsored** ### Rockbot Rockbot is a comprehensive media-for-business solution designed to enhance in-location customer experiences through a unified platform that offers fully licensed music, TV, digital signage, and retail media advertising. Established in 2010, Rockbot has positioned itself as a leader in the industry, equipping businesses with the necessary tools to effectively engage customers and foster an inviting atmosphere that promotes loyalty and satisfaction. Targeting a diverse audience that includes large corporations, franchises, and small to medium-sized businesses (SMBs), Rockbot serves various sectors such as retail, fitness, hospitality, and dining. The platform is particularly advantageous for businesses aiming to create a cohesive brand experience across multiple locations. By integrating different types of media, Rockbot enables businesses to customize their content to reflect their brand identity and cater to customer preferences, ensuring that every visit leaves a lasting impression. One of Rockbot's standout features is its ability to deliver curated music playlists that resonate with the brand's image and the demographic of its clientele. This capability not only enhances the overall ambiance but also helps set the right mood for various times of the day or special events. Furthermore, Rockbot's digital signage functionality allows businesses to showcase promotional content, announcements, or engaging visuals that capture customer attention and drive sales, thereby enhancing the overall customer experience. In addition to its media offerings, Rockbot provides a robust advertising solution that enables businesses to monetize their media space. By collaborating with trusted brands, businesses can generate additional revenue while delivering relevant content to their customers. This dual focus on enriching customer experiences while creating revenue opportunities distinguishes Rockbot in the competitive media-for-business landscape. With the support of Google Ventures and a client roster that includes well-known names like Planet Fitness, Walmart, Shake Shack, and Ashley Furniture, Rockbot has demonstrated its reliability and effectiveness. The platform is designed with user-friendliness in mind, allowing businesses to manage their media content with ease. This simplicity, combined with the ability to customize and adapt content in real-time, makes Rockbot a valuable asset for any business seeking to enhance its customer engagement strategy. [Visit website](https://www.g2.com/external_clickthroughs/record?secure%5Bad_program%5D=ppc&secure%5Bad_slot%5D=category_product_list_llm&secure%5Bcategory_id%5D=1005359&secure%5Bchosen_at%5D=2026-08-05T02%3A13%3A45Z&secure%5Bdisplayable_resource_id%5D=1838&secure%5Bdisplayable_resource_type%5D=Category&secure%5Bmedium%5D=sponsored&secure%5Bplacement_reason%5D=retargeted_product&secure%5Bplacement_resource_ids%5D%5B%5D=100407&secure%5Bprioritized%5D=false&secure%5Bproduct_id%5D=100407&secure%5Bresource_id%5D=1005359&secure%5Bresource_type%5D=Category&secure%5Bsource_type%5D=category_page&secure%5Bsource_url%5D=https%3A%2F%2Fwww.g2.com%2Fcategories%2Fregulatory-information-management-rim-systems%3Fpage%3D4&secure%5Btoken%5D=4c18415be9cd1fe9608380b22dbca8051c5357aecf663483c9d1894d7f137cd3&secure%5Burl%5D=https%3A%2F%2Fbuy.rockbot.com%2Ftrial&secure%5Burl_type%5D=free_trial) ### [Revisto](https://www.g2.com/products/revisto/reviews) Revisto is an AI-powered platform designed to enhance the efficiency and accuracy of content creation processes, particularly in regulated industries. By automating the detection of regulatory requirements, Revisto ensures that promotional materials comply with relevant FDA 21 CFR regulations and company-specific guidelines. This automation reduces the need for manual checks, streamlining workflows and maintaining consistency across multiple brands. The platform's intuitive interface highlights satisfied rules and flags potential violations, allowing reviewers to focus on critical areas. Additionally, Revisto facilitates in-context collaboration and commenting, promoting decisive action and quick resolution of issues. By optimizing the Medical, Legal, and Regulatory (MLR) workflow, Revisto helps organizations improve time to market, simplify compliance, and save time, potentially leading to annual savings exceeding $15 million. #### Who Is the Company Behind Revisto? - **Seller:** [Revisto](https://www.g2.com/sellers/revisto) - **HQ Location:** Austin, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c5effb8292c27ee3ee73e28e5c717eec5d2e6e9beee8379580fcd85dbbfaf0c0&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Frevisto-inc&secure%5Burl_type%5D=linkedin_company_website) 14 employees on LinkedIn® ### [RIMTrack](https://www.g2.com/products/rimtrack/reviews) RIMTrack is a cloud-based, AI-enabled Regulatory Information Management (RIM system designed to streamline and enhance the regulatory processes within the healthcare and life sciences industries. It assists organizations in preparing accurate and efficient submissions, managing licensing and approvals, and conducting regulatory and competitive intelligence across global sites and stakeholders. RIMTrack seamlessly integrates with existing systems, ensuring data security and compliance with evolving national regulations and data standards. Key Features and Functionality: - End-to-End Regulatory Lifecycle Management: Integrates with existing RIM systems to provide comprehensive management of the regulatory lifecycle. - Enhanced Speed and Accuracy: Improves the efficiency and precision of the submission process, helping organizations stay ahead of regulatory compliance requirements. - Operational Expenditure Reduction: Eliminates or reduces reliance on legacy systems, streamlining regulatory information tracking and reducing operational costs. - Improved Collaboration and Data Quality: Facilitates better collaboration among stakeholders and enhances data quality, tracking, compliance adherence, consistency, and accountability. Primary Value and Problem Solved: RIMTrack addresses the challenges posed by constantly changing regulations and complex submission processes in the healthcare and life sciences sectors. By providing a cloud-ready, AI-based solution, it enables organizations to optimize costs, maximize accuracy, and minimize timelines for regulatory submissions. This leads to enhanced collaboration, improved data quality, and reduced complexity, ultimately resulting in faster time-to-market and increased revenue. #### Who Is the Company Behind RIMTrack? - **Seller:** [WinWire](https://www.g2.com/sellers/winwire) - **HQ Location:** Santa Clara, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=d2b5488537cef2fa7800e884dc65eeeb010b121eaf22603ba42118500e9fbb38&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fwinwire&secure%5Burl_type%5D=linkedin_company_website) 1,035 employees on LinkedIn® ### [Sarjen's RIMS](https://www.g2.com/products/sarjen-s-rims/reviews) Sarjen's RIMS (Regulatory Information Management System) is a centralized, IDMP-compliant platform that streamlines and automates regulatory processes for the life sciences industry. The solution uses intuitive workflows to efficiently track data, ensuring global compliance. By centralizing regulatory data, RIMS allows for easy tracking of submissions, approvals, variations, and renewals, which improves overall efficiency and reduces manual errors. The system helps manage the entire product lifecycle from registration to approval and supports data-driven decision-making, leading to faster go-to-market timelines and reduced operational costs. #### Who Is the Company Behind Sarjen's RIMS? - **Seller:** [Sarjen System](https://www.g2.com/sellers/sarjen-system) - **Year Founded:** 1998 - **HQ Location:** N/A - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=ceab8a44a8b52be607ebfe47559a8dd9198210eba11c1b1093dafe117a5aa0b6&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F1007381&secure%5Burl_type%5D=linkedin_company_website) 369 employees on LinkedIn® ### [UDI Excel Cloud Validator](https://www.g2.com/products/udi-excel-cloud-validator/reviews) Validate UDI Excel for EUDAMED and FDA GUDID—fast, precise, and fully in the cloud. The UDI Excel Cloud Validator helps MedTech teams catch format and content issues before submission. You sign in via browser, select the target authority, and upload your Excel file. Within seconds, the app returns row-level feedback with clear hints on how to fix each finding. When you’re ready, you can download a detailed Excel or CSV report for review and collaboration. #### Who Is the Company Behind UDI Excel Cloud Validator? - **Seller:** [Europe IT Consulting](https://www.g2.com/sellers/europe-it-consulting) - **Year Founded:** 2011 - **HQ Location:** Basel, CH - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=e26347cb25a7f49fc18594438cc97b6a56ab9317bee4b26e0a79a838b1548a8b&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Feurope-it-consulting-gmbh%2F&secure%5Burl_type%5D=linkedin_company_website) 8 employees on LinkedIn® ### [Veeva Quickvault](https://www.g2.com/products/veeva-quickvault/reviews) QuickVault by Veeva is the leading device-to-market solution for small MedTech companies. Built for full device lifecycle support, the platform unifies design, regulatory, quality, and post-commercial operations in one scalable environment — helping teams stay agile, compliant, and ready to grow. From concept through commercialization and beyond, QuickVault by Veeva gives MedTech companies the visibility and control they need to deliver safe, effective products to patients and succeed at every stage. #### Who Is the Company Behind Veeva Quickvault? - **Seller:** [Veeva](https://www.g2.com/sellers/veeva) - **Year Founded:** 2007 - **HQ Location:** Pleasanton, CA - **Twitter:** @veevasystems 6,133 Twitter followers - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=09d1882ac479495db33963e82af224cfab6bd595516d089eb06329a0022b3561&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F402048%2F&secure%5Burl_type%5D=linkedin_company_website) 9,958 employees on LinkedIn® - **Ownership:** NYSE: VEEV ### [Zelthy-Clinical Study Report Drafting](https://www.g2.com/products/zelthy-clinical-study-report-drafting/reviews) What is this product? Zelthy Clinical Study Report Drafting is an AI-assisted application for pharmaceutical regulatory and clinical teams preparing clinical study reports. It provides AI-assisted section drafting grounded in study data, quality review against ICH E3 guidelines, cross-reference validation between CSR sections and source data, and multi-stakeholder review workflows — accelerating CSR preparation while maintaining regulatory quality standards. Key Features & Functionalities - AI-assisted section drafting grounded in study data - Quality review against ICH E3 guideline requirements - Cross-reference validation between CSR sections and source data - Multi-stakeholder review workflows with comment management - Template management for CSR sections Primary Solution & Value Clinical study reports are foundational documents in every regulatory submission — yet drafting them is time-intensive, requiring careful alignment between statistical outputs, clinical narratives, and ICH E3 requirements. This application uses AI to accelerate drafting while maintaining cross-reference integrity, enabling regulatory teams to prepare CSRs faster without sacrificing quality. #### Who Is the Company Behind Zelthy-Clinical Study Report Drafting? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Dossier Assembly & eCTD](https://www.g2.com/products/zelthy-dossier-assembly-ectd/reviews) What is this product? Zelthy Dossier Assembly & eCTD is an application for pharmaceutical regulatory teams assembling submission dossiers. It organizes documents per ICH CTD module structure (Modules 1–5), manages multi-stakeholder review and approval workflows, validates publishing-ready packages against eCTD technical requirements, and generates submission-ready packages for health authority filing. Key Features & Functionalities - Document organization per ICH CTD module structure - Multi-stakeholder review and approval workflows - eCTD publishing validation against technical requirements - Submission package generation for health authority filing - Version control and document lifecycle management Primary Solution & Value Regulatory dossier assembly involves coordinating hundreds of documents across multiple contributors, organized per strict CTD module structure. Errors in assembly — missing documents, incorrect module placement, publishing validation failures — delay submissions and health authority acceptance. This application provides structured assembly workflows with built-in validation, reducing submission errors and cycle time. #### Who Is the Company Behind Zelthy-Dossier Assembly & eCTD? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Labelling Management](https://www.g2.com/products/zelthy-labelling-management/reviews) What is this product? Zelthy Labelling Management is an application for pharmaceutical regulatory teams managing product labeling across markets. It maintains the core data sheet as the single source of truth, manages local market label adaptations per jurisdiction requirements, coordinates artwork changes with packaging teams, and assesses the impact of labeling changes across all registered markets — ensuring consistency across the global label portfolio. Key Features & Functionalities - Core data sheet management as single source of truth - Local market label adaptation per jurisdiction requirements - Artwork coordination with packaging teams - Change impact analysis across registered markets - Label version control and approval workflows Primary Solution & Value A single labeling change can affect dozens of markets, each with different regulatory requirements for implementation. Without structured change management, labeling inconsistencies across markets create compliance risk. This application manages the cascade from core data sheet change through local adaptations, ensuring every market's label remains consistent and compliant. #### Who Is the Company Behind Zelthy-Labelling Management? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Pharmacovigilance & AE Management](https://www.g2.com/products/zelthy-pharmacovigilance-ae-management/reviews) What is this product? Zelthy Pharmacovigilance & AE Management is an application for pharmaceutical drug safety teams managing adverse event operations. It covers the full AE lifecycle: multi-channel intake (calls, emails, field reports, literature), case processing and medical assessment, deadline-driven regulatory reporting, signal detection and trending, and health authority submission formatting — providing a structured workflow for the time-critical requirements of pharmacovigilance. Key Features & Functionalities - Multi-channel adverse event intake (calls, email, social, field, literature) - Case processing with medical assessment workflows - Deadline management for regulatory reporting timelines - Submission formatting per health authority requirements - Signal detection and safety trending analytics Primary Solution & Value Pharmacovigilance is one of the most time-critical and regulated functions in pharma — serious adverse events must be reported to health authorities within strict timelines. Manual case processing and deadline tracking creates risk of missed submissions. This application structures the AE lifecycle from intake through submission, ensuring regulatory timelines are met and emerging safety signals are detected early. #### Who Is the Company Behind Zelthy-Pharmacovigilance & AE Management? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy Regulatory Affairs](https://www.g2.com/products/zelthy-regulatory-affairs/reviews) Zelthy Regulatory Affairs is an AI-powered regulatory authoring workspace for pharmaceutical and biotech companies preparing FDA and EMA dossier submissions. It provides a unified document library where regulatory teams import source documents — Clinical Study Reports (CSRs), CDISC datasets (SDTM, ADaM), Tables, Listings and Figures (TLFs), Investigator Brochures, and Protocols, and use AI to author synthesis documents including CTD Module 2 summaries (2.5 Clinical Overview, 2.7 Clinical Summaries), US Prescribing Information (USPI), FDA correspondence, and Integrated Summaries of Safety and Efficacy (ISS, ISE). Key features and functionalities Zelthy Draft ships with four AI agents operating across the full dossier lifecycle: - a Dossier Consistency Agent that reads all imported documents simultaneously and flags discrepancies in efficacy data, safety data, subject counts, and dosing information across CSRs, summaries, and labelling; - a Gap Analysis Agent that maps the assembled dossier against FDA and EMA guidance requirements, identifies missing data sections, and surfaces unanswered regulatory questions before they become FDA queries; - an AI Drafting Agent that authors first drafts of Module 2 summaries, USPI, and FDA correspondence grounded entirely in the imported source evidence, with every AI-generated claim linked back to the source document and page number; - and a Regulatory Intelligence Agent that monitors FDA and EMA guidance updates, tracks precedent decisions on similar molecules, and surfaces relevant intelligence during the authoring process. The full document library is AI-searchable and cross-referenceable, with collaborative review workflows, document version control, eCTD structure and formatting support, and a complete audit trail on all AI-generated content. Primary value and solution provided Regulatory dossier authoring is one of the most time-consuming and error-prone activities in pharmaceutical drug development. A typical CTD Module 2 submission involves synthesising hundreds of pages across dozens of source documents, and a single data inconsistency or missed regulatory requirement can trigger a Complete Response Letter that delays approval by 12 months or more. Zelthy Draft reduces both the time and the risk. The Consistency Agent catches cross-document discrepancies that human reviewers routinely miss when working under deadline pressure. The Gap Analysis Agent identifies submission-readiness issues weeks before the filing date rather than days before. And the AI Drafting Agent, which produces citation-traced first drafts grounded in imported evidence rather than generating unsupported text, reduces Module 2 authoring time by 60–70%, giving small regulatory teams the throughput to compete with larger organisations without proportionally larger headcount. #### Who Is the Company Behind Zelthy Regulatory Affairs? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Regulatory Compliance Reporting](https://www.g2.com/products/zelthy-regulatory-compliance-reporting/reviews) What is this product? Zelthy Regulatory Compliance Reporting is an application for pharmaceutical companies managing traceability reporting obligations across multiple jurisdictions. It automates the preparation and submission of compliance reports per jurisdiction-specific requirements — DSCSA (US), EU FMD (Europe), India DCTS, and other emerging market regulations — with pre-submission validation and exception management to prevent submission failures. Key Features & Functionalities - Multi-market regulatory reporting (DSCSA, EU FMD, India DCTS, and more) - Automated report generation per jurisdiction requirements - Pre-submission validation with error detection - Exception management and remediation workflows - Audit trail for all submissions and corrections Primary Solution & Value Pharmaceutical companies operating across markets face different traceability reporting requirements in each jurisdiction — with different formats, submission timelines, and compliance standards. Manual report preparation across multiple regulatory bodies is error-prone and time-consuming. This application automates multi-market reporting from a single traceability data set, reducing compliance risk and submission errors. #### Who Is the Company Behind Zelthy-Regulatory Compliance Reporting? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Regulatory Intelligence](https://www.g2.com/products/zelthy-regulatory-intelligence/reviews) What is this product? Zelthy Regulatory Intelligence is an application for pharmaceutical regulatory affairs teams monitoring the regulatory landscape across jurisdictions. It uses AI to track guideline changes, new requirements, and precedent decisions from health authorities, and assesses the impact on the company's product portfolio — enabling proactive regulatory planning rather than reactive response. Key Features & Functionalities - AI-powered monitoring of health authority guideline changes - Impact assessment against active product portfolio - Precedent decision tracking and analysis - Multi-jurisdiction regulatory change calendar - Alerts and notifications for relevant requirement changes Primary Solution & Value Health authority guidelines and requirements change continuously across jurisdictions. Regulatory teams that discover changes late face rushed submissions and compliance gaps. This application provides automated monitoring with portfolio impact analysis, enabling regulatory teams to plan proactively for requirement changes rather than responding after deadlines are compressed. #### Who Is the Company Behind Zelthy-Regulatory Intelligence? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Submission Pipeline Management](https://www.g2.com/products/zelthy-submission-pipeline-management/reviews) What is this product? Zelthy Submission Pipeline Management is an application for pharmaceutical regulatory affairs teams managing active submissions across health authorities. It provides a unified view of all submissions — status tracking, milestone management, health authority query coordination, and review clock monitoring — giving regulatory leaders visibility into pipeline progress across jurisdictions from a single dashboard. Key Features & Functionalities - Unified submission pipeline dashboard across jurisdictions - Health authority query management with response tracking - Milestone tracking with review clock monitoring - Cross-functional coordination for submission deliverables - Pipeline analytics and capacity planning tools Primary Solution & Value Regulatory teams managing submissions across multiple health authorities often track status in spreadsheets or fragmented systems — creating visibility gaps and coordination delays. This application provides a single source of truth for submission pipeline status, enabling regulatory leaders to monitor progress, anticipate bottlenecks, and coordinate resources across jurisdictions. #### Who Is the Company Behind Zelthy-Submission Pipeline Management? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® ### [Zelthy-Variation & Change Management](https://www.g2.com/products/zelthy-variation-change-management/reviews) What is this product? Zelthy Variation & Change Management is an application for pharmaceutical regulatory teams managing post-approval changes to marketed products. It handles variation classification per jurisdiction-specific rules, submission preparation with required documentation, and cross-jurisdiction tracking to ensure variations are filed consistently across all markets where a product is registered. Key Features & Functionalities - Variation classification per jurisdiction-specific rules - Submission preparation with documentation checklists - Cross-jurisdiction tracking for multi-market variations - Regulatory authority response management - Variation analytics and portfolio reporting Primary Solution & Value Post-approval changes — formulation, manufacturing site, labeling — require regulatory filings (variations) in every market where the product is registered. Different jurisdictions classify the same change differently, with different documentation and timelines. This application manages the complexity of multi-market variation filings, ensuring changes are classified, filed, and tracked consistently across jurisdictions. #### Who Is the Company Behind Zelthy-Variation & Change Management? - **Seller:** [Zelthy](https://www.g2.com/sellers/zelthy-2026-07-16) - **Year Founded:** 2017 - **HQ Location:** Seattle, US - **LinkedIn® Page:** [www.linkedin.com](https://www.g2.com/external_clickthroughs/record?secure%5Bsource_type%5D=product_profile&secure%5Btoken%5D=c2ee5c63810720eac3126d408f4ab408b1a0d6a37dc5d8220e1c3795c8dc9dfd&secure%5Burl%5D=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fzelthy1&secure%5Burl_type%5D=linkedin_company_website) 33 employees on LinkedIn® - [‹ Prev‹ Prev](/categories/regulatory-information-management-rim-systems?order=g2_score&page=3#product-list) - [1](/categories/regulatory-information-management-rim-systems?order=g2_score#product-list) - [2](/categories/regulatory-information-management-rim-systems?order=g2_score&page=2#product-list) - [3](/categories/regulatory-information-management-rim-systems?order=g2_score&page=3#product-list) - 4 - Next ›Next › Spotlight Categories [HCM Software](https://www.g2.com/categories/hcm-software) [Environmental Health and Safety Software](https://www.g2.com/categories/environmental-health-and-safety) [E-commerce Fraud Protection Software](https://www.g2.com/categories/e-commerce-fraud-protection) [VoIP Providers](https://www.g2.com/categories/voip) [Marketing Analytics Tools](https://www.g2.com/categories/marketing-analytics) Similar Categories - [Clinical Research](/categories/clinical-research) - [Drug Discovery](/categories/drug-discovery) - [Medical QMS](/categories/medical-qms) - [Other Life Sciences](/categories/other-life-sciences) - [Pharma and Biotech](/categories/pharma-and-biotech) [Browse Regulatory Information Management (RIM) Systems Themes](/categories/regulatory-information-management-rim-systems/themes) ![Emma Stein](/assets/transparent-ad5be28fbcd25b7b08d2cebe1d957125437fb5407d75ee717965ad22c8808791.gif "Emma Stein") ES Researched and written by [Emma Stein](https://research.g2.com/insights/author/emma-stein) Updated October 3, 2024 Regulatory information management (RIM) systems provide a centralized record of regulatory documents and activities throughout the product development lifecycle for pharmaceutical and medtech companies. Regulatory affairs (RA) professionals rely on these systems to maintain up-to-date information for each product and ensure it meets all regional regulatory requirements to obtain market clearance and conduct post-market surveillance. RIM systems enable collaborative authoring on supporting documentation pertaining to regulatory submissions, product registration, unique device identifier (UDI) labels, essential principles, and standards management. They also provide high-level visibility into every step of the pre-to-post-market lifecycle, streamlining the auditing process. Once a product is in the post-market stage, RA teams use RIM systems to collect important product data around safety and performance and take any necessary actions. RIM systems connect information from multiple systems, such as [medical quality management systems (QMS)](https://www.g2.com/categories/medical-qms), and create a centralized location to track product registration status, collaborate on regulatory submission documents, and improve project management workflows. Some RIM systems may offer regulatory intelligence support, allowing RA teams to monitor changes in standards and regulations and proactively accommodate those changes before they impact the selling status of products. To qualify for inclusion in the Regulatory Information Management (RIM) Systems category, a product must: - Track detailed product information and regulatory documentation for each product - Provide regulatory document authoring tools and monitor dossier submission pipelines - Provide project management features and visibility into tasks, requests, and approvals around regulatory activities - Support post-market surveillance activities, such as feedback - Integrate with QMS and PLM solutions to support data centralization Show More